How an Interest in Bipolar Disorder Drugs Led to a Better Understanding of Leukemia

News   Nov 01, 2017 | Original Story from American Society for Biochemistry and Molecular Biology.

 
How an Interest in Bipolar Disorder Drugs Led to a Better Understanding of Leukemia

A new project reveals that the enzyme GSK-3, a target of the mood disorder drug lithium, has a role in controlling alternative splicing in cells. This observation may yield insights into leukemia. Credit: Mansi Shinde and Simone Sidoli.

 
 
 

RELATED ARTICLES

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

Take Charge, Wine Lovers, and Trust Your Palate

News

New research suggests people generally fit into certain wine-drinking categories, or “vinotypes,” and that servers and sommeliers should consider these preferences when suggesting a wine.

READ MORE

Cinnamon Turns Up the Heat on Fat Cells

News

New research indicates that cinnamaldehyde, found in cinnamon, improves metabolic health by acting directly on fat cells, or adipocytes, inducing them to start burning energy through a process called thermogenesis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE